Dec 31, 2021 05:09 PM (GMT+8) · EqualOcean
Financial Associated Press, December 31 - Fosun Pharmaceutical announced that on December 31, 2021, Fosun Pharmaceutical industry, the holding subsidiary of the company, signed the equity transfer agreement with Weibo Wang. Fosun Pharmaceutical industry plans to make a cash contribution of US $141 million to transfer the 23.9992% equity of Chongqing fuchuang held by Weibo Wang (corresponding to the paid in registered capital of US $3.429 million). After the completion of this transfer, Fosun Pharmaceutical Industry and its holding subsidiaries Jiangsu Wanbang and Chongqing Medical Engineering Institute will jointly hold 100% equity of Chongqing fuchuang.

This text is a result of machine translation.